HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

tasimelteon

Also Known As:
BMS 214778; BMS-214778; BMS214778; N-((2-(2,3-dihydro-4-benzofuranyl)cyclopropyl)methyl)propanamide
Networked: 37 relevant articles (7 outcomes, 11 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Polymeropoulos, Mihael H: 5 articles (01/2022 - 02/2009)
2. Torres, Rosarelis: 5 articles (01/2022 - 05/2015)
3. Dressman, Marlene A: 5 articles (01/2016 - 01/2015)
4. Birznieks, Gunther: 4 articles (01/2022 - 02/2009)
5. Xiao, Changfu: 4 articles (01/2022 - 10/2015)
6. Baroldi, Paolo: 3 articles (09/2015 - 05/2015)
7. Kramer, William G: 3 articles (09/2015 - 05/2015)
8. Polymeropoulos, Christos M: 2 articles (12/2021 - 01/2020)
9. Fisher, Dennis M: 2 articles (10/2015 - 02/2009)
10. Lavedan, Christian: 2 articles (10/2015 - 04/2015)

Related Diseases

1. Jet Lag Syndrome
2. Sleep Wake Disorders
3. Sleep Initiation and Maintenance Disorders (Insomnia)
4. Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome)
5. Sleepiness

Related Drugs and Biologics

1. Melatonin
2. Melatonin Receptors (Melatonin Receptor)
3. ramelteon (Rozerem)
4. agomelatine (S20098)
5. Alanine Transaminase (SGPT)
6. Enzymes
7. N- (2- (5- methoxy- indol- 3- yl)- ethyl)- 4- oxo- 4H- pyran- 2- carboxamide
8. Neurotransmitter Agents (Neurotransmitter)
9. Serotonin (5 Hydroxytryptamine)
10. Iron

Related Therapies and Procedures

1. Therapeutics
2. Phototherapy (Light Therapy)